Furthermore, AFP is an important molecule acting against paclitaxel-induced proliferation inhibition and apoptosis in HCC cells, which indicated that inhibiting AFP expression after treatment with paclitaxel may be an available strategy for the treatment of HCC [40]. The gene discussed is AFP; the disease is hepatocellular carcinoma.